LOS ANGELES, May 1, 2023 /PRNewswire/ -- ACELYRIN, INC., a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today announced it has launched a roadshow for an initial public offering (IPO) of 20,600,000...
News Ticker
- [ June 5, 2023 ] Amgen continues to target mid-December deadline for Horizon deal close Los Angeles Biotech News
- [ June 5, 2023 ] Akero’s NASH candidate reduces liver fat in patients taking a GLP-1 Los Angeles Biotech News
- [ June 5, 2023 ] Pharmaceutical Visual Inspector Technician – MedisourceRx – Los Alamitos, CA Los Angeles Biotech Jobs
- [ June 5, 2023 ] Atara Biotherapeutics Presents Updated Tab-cel® Clinical Effectiveness Data at ASCO 2023 Los Angeles Biotech News
- [ June 5, 2023 ] Bansk Group-Backed Arcadia Consumer Health Acquires Avrio Health Los Angeles Biotech News
Copyright © 2021 Biotech Networks, LLC
